Dual-Multivalent Aptamer-Based Drug Delivery Platform for Targeted SRC Silencing to Enhance Doxorubicin Sensitivity in Endometrial CancerHaojia Li, Hongbo Wang|International Journal of Biological Sciences|2024Cited by 7